The programme will include plenary sessions, educational tracks in the fields of Hematology-Oncology, Data analysis and Immunology, and  abstract and poster presentations. 

The final full programme is now available

On Wednesday 27 September 2023 five pre-conference workshops will be offered to a limited number of participants. Pre-registration required. Fee: € 100.

MRD in AML Fully booked
Level: Advanced. Max. 20 places.
Choice and intensity of treatment of acute myeloid leukemia (AML) patients is based on prognostic risk classification. One of the most important prognostic factors in AML is measurable residual disease (MRD) after intensive chemotherapy. Hence, AML-MRD evaluation has been incorporated in clinical practice to select the appropriate consolidation treatment. Although molecular techniques are available, flow cytometry is the most commonly technique used for AML-MRD assessment. In this course we will present the European Leukemia Net guidelines, discuss the pros and cons of external quality assessment, provide details on key aspects of the pre-analytical phase, and conclude with a hands-on practical session.
Download the preliminary programme here

Tips and tricks for optimizing instruments and experiments
Level: Basic-Intermediate. Max. 40 places. 
How confident are you with your flow cytometry data? Are you sure you can reproduce your assay in a different lab? Are you sure that the data that you obtain with your flow cytometer cannot be improved? There are many variables when we are setting up a flow cytometer which can be optimized to improve the quality of your data and its reproducibility, such as panel design, titration of the antibodies, the fluidics of the instrument and or the adjustment of voltages/gains in our flow cytometers. In the same way that a Titration assay, the voltration/gaintration of our instruments will help us to properly distinguish our populations but also to perform a more accurate analysis. These could also help us to improve our compensation matrixes. Therefore, understanding why and how to perform the titration of our reagents as well as a voltration/gaintration of our instruments is a key element for optimising our assays. During this theoretical/practical workshop, we will cover these aspects and participants will see in real samples the big differences in the data between an optimized and a non-optimized assay/instrument. 
Download the programme here

A practical guide to monocytosis
Level: Intermediate. Max. 20 places.
The partitioning of peripheral blood monocyte subsets evaluated by flow cytometry, so-called “monocyte assay”, is now part of the exploration of monocytosis as it has been demonstrated to be a powerful tool for chronic myelomonocytic leukemia (CMML) diagnosis. The recent 5th edition of the WHO classification identified the monocyte assay as a supporting criteria for CMML diagnosis. In this curse we will review the utility of the monocyte assay and its implementation in routine laboratory, including instrument settings, sample preparation, data analysis, interpretation, foremost pitfalls and reporting.
Download the programme here

Measurable residual disease in MM Fully booked
Level: Advanced. Max. 20 places.
Measurable residual disease (MRD) detection during follow-up is one of the aspects currently drawing more attention in multiple myeloma (MM). Growing evidence is being gathered that confirms the clinical relevance of MRD detection, particularly for the most recent high-sensitive methodologies, as they continue to move closer to the routine clinical laboratory. In this course we will review the utility of MRD detection in clinical practice and, deepen our understanding on the Next Generation Flow methodology by gaining first-hand practical experience on data analysis, interpretation and reporting.
Download the programme here

Peripheral blood LPD analysis: an introductory course for the beginner
This workshop has been cancelled.